- Home
- CCM vs PASG Comparison
CCM vs PASG Comparison
Compare CCM & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- PASG
- Stock Information
- Founded
- CCM 1997
- PASG 2017
- Country
- CCM China
- PASG United States
- Employees
- CCM N/A
- PASG N/A
- Industry
- CCM Medical/Nursing Services
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- PASG Health Care
- Exchange
- CCM Nasdaq
- PASG Nasdaq
- Market Cap
- CCM 23.8M
- PASG 27.6M
- IPO Year
- CCM 2009
- PASG 2020
- Fundamental
- Price
- CCM $4.93
- PASG $6.25
- Analyst Decision
- CCM
- PASG Strong Buy
- Analyst Count
- CCM 0
- PASG 4
- Target Price
- CCM N/A
- PASG $59.25
- AVG Volume (30 Days)
- CCM 42.4K
- PASG 36.3K
- Earning Date
- CCM 09-26-2025
- PASG 11-10-2025
- Dividend Yield
- CCM N/A
- PASG N/A
- EPS Growth
- CCM N/A
- PASG N/A
- EPS
- CCM N/A
- PASG N/A
- Revenue
- CCM $51,056,841.00
- PASG N/A
- Revenue This Year
- CCM N/A
- PASG N/A
- Revenue Next Year
- CCM N/A
- PASG N/A
- P/E Ratio
- CCM N/A
- PASG N/A
- Revenue Growth
- CCM N/A
- PASG N/A
- 52 Week Low
- CCM $3.80
- PASG $5.12
- 52 Week High
- CCM $10.77
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- CCM 38.25
- PASG 33.73
- Support Level
- CCM $5.18
- PASG $6.56
- Resistance Level
- CCM $5.77
- PASG $7.91
- Average True Range (ATR)
- CCM 0.46
- PASG 0.57
- MACD
- CCM -0.03
- PASG -0.19
- Stochastic Oscillator
- CCM 8.66
- PASG 6.71
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.